Fortis Healthcare Sees Sharp Open Interest Surge Amidst Bullish Momentum

Open Interest and Volume Dynamics

On 11 Feb 2026, Fortis Healthcare’s open interest (OI) in derivatives rose sharply by 3,880 contracts, a 17.49% increase from the previous day’s 22,183 to 26,063. This notable expansion in OI was accompanied by a robust volume of 41,375 contracts, underscoring active participation from traders and institutional investors alike. The futures segment alone accounted for a value of approximately ₹23,077.47 lakhs, while options contributed a staggering ₹27,879.84 crores in notional value, culminating in a total derivatives value of ₹28,402.85 lakhs.

Such a pronounced rise in open interest, coupled with elevated volumes, typically indicates fresh capital inflows and the establishment of new positions rather than mere unwinding of existing trades. This suggests that market participants are increasingly positioning themselves for a directional move in Fortis Healthcare’s stock price.

Price Performance and Technical Context

Fortis Healthcare’s underlying equity price has mirrored this bullish sentiment, gaining 3.70% on the day to close near ₹924, with an intraday high touching ₹930.90, a 4.38% rise. The stock has been on a three-day consecutive gain streak, delivering an impressive 8.31% return over this period. Notably, the stock outperformed its Hospital & Healthcare Services sector, which itself advanced by 3.4%, and the broader Sensex, which rose a modest 0.16% on the same day.

From a technical standpoint, Fortis’s price currently trades above its 5-day, 20-day, 50-day, and 200-day moving averages, signalling sustained short- and medium-term strength. However, it remains below the 100-day moving average, indicating some resistance at higher levels that traders will be watching closely. This mixed technical picture suggests a cautiously optimistic outlook, with room for further upside if the stock can breach this key moving average.

Market Positioning and Investor Behaviour

The surge in derivatives open interest aligns with a shift in market positioning towards a more bullish stance. The increase in futures and options activity points to investors placing directional bets, likely anticipating continued upward momentum in Fortis Healthcare’s shares. This is further supported by the stock’s liquidity profile, which remains adequate for sizeable trades, with a 2% threshold of the 5-day average traded value allowing for trade sizes up to ₹2.12 crores without significant market impact.

However, it is important to note a decline in delivery volume, which fell by 24.08% to 6.13 lakh shares on 10 Feb compared to the 5-day average. This suggests that while speculative activity in derivatives is rising, actual investor participation in the cash segment is somewhat subdued. Such divergence often indicates that short-term traders and hedge funds are driving the recent momentum, rather than long-term investors committing fresh capital.

Mojo Score and Analyst Ratings

Fortis Healthcare currently holds a Mojo Score of 65.0, categorised as a ‘Hold’ rating, reflecting a cautious stance from analysts. This represents a downgrade from a previous ‘Buy’ rating assigned on 13 Jan 2025, signalling a tempered outlook amid evolving market conditions. The company’s market capitalisation stands at ₹68,928 crores, placing it firmly in the mid-cap segment with a Market Cap Grade of 2.

While the stock’s recent outperformance and derivatives activity suggest renewed investor interest, the downgrade indicates that analysts are weighing potential headwinds such as sectoral competition, regulatory risks, or valuation concerns. Investors should therefore balance the positive momentum against these cautionary signals.

Sectoral and Broader Market Context

The Hospital & Healthcare Services sector has shown resilience, gaining 3.4% on the day, supported by improving demand for healthcare services and increased investor focus on defensive sectors amid broader market volatility. Fortis Healthcare’s outperformance relative to its sector peers highlights its leadership position and potential to capitalise on sector tailwinds.

However, the broader market environment remains mixed, with the Sensex posting only a marginal gain of 0.16%. This divergence emphasises the selective nature of current market rallies, where quality mid-cap stocks with strong fundamentals and positive technical signals are attracting disproportionate investor interest.

Implications for Investors and Traders

The sharp increase in open interest and volume in Fortis Healthcare’s derivatives suggests that traders are positioning for a sustained upward move. This is supported by the stock’s recent price strength and technical indicators. However, the decline in delivery volumes signals that long-term investor conviction may not yet be fully established, warranting a degree of caution.

Investors should monitor whether the stock can maintain momentum above the 100-day moving average, which remains a critical resistance level. A decisive breakout could trigger further buying interest and validate the bullish positioning seen in the derivatives market.

Conversely, any failure to sustain gains or a reversal in open interest trends could indicate profit-taking or a shift in sentiment, especially given the recent downgrade in analyst ratings. As always, a balanced approach considering both technical signals and fundamental factors is advisable.

Conclusion

Fortis Healthcare Ltd’s recent surge in derivatives open interest and volume reflects a growing bullish sentiment among traders, supported by strong price performance and sectoral gains. While the stock’s Mojo Score downgrade to ‘Hold’ tempers enthusiasm, the technical and market positioning data suggest potential for further upside if key resistance levels are breached. Investors should remain vigilant to evolving market dynamics and consider both the opportunities and risks inherent in this mid-cap healthcare stock.

Unlock special upgrade rates for a limited period. Start Saving Now →